HUP0100303A2 - Porózus hidroxiapatit részecskék mint gyógyszerhatóanyag hordozók - Google Patents

Porózus hidroxiapatit részecskék mint gyógyszerhatóanyag hordozók

Info

Publication number
HUP0100303A2
HUP0100303A2 HU0100303A HUP0100303A HUP0100303A2 HU P0100303 A2 HUP0100303 A2 HU P0100303A2 HU 0100303 A HU0100303 A HU 0100303A HU P0100303 A HUP0100303 A HU P0100303A HU P0100303 A2 HUP0100303 A2 HU P0100303A2
Authority
HU
Hungary
Prior art keywords
composition
carriers
drug substances
hydroxyapatite particles
porous hydroxyapatite
Prior art date
Application number
HU0100303A
Other languages
English (en)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Söderbom
Original Assignee
Astrazeneca Ab,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, filed Critical Astrazeneca Ab,
Publication of HUP0100303A2 publication Critical patent/HUP0100303A2/hu
Publication of HUP0100303A3 publication Critical patent/HUP0100303A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgyát olyan száraz, szilárd gyógyszeradagoló kompozícióképezi, amely tartalmaz i) legalább egy zsíros, olajos vagy ragacsosanyagot és legalább egy gyógyszerhatóanyagot; vagy ii) legalább egyzsíros, olajos vagy ragacsos gyógyszerhatóanyagot, amely kompozíció 5és 150 mm közötti átmérőjű kerámiai hidroxiapatitból álló porózusszervetlen részecskék többségének formájában van; a hatóanyag gyorsfelszabadítási tulajdonságaival rendelkezik, és az i) vagy ii)komponenst 15 és 40 tömeg% közötti mennyiségben tartalmazza. Atalálmány tárgyát képezi még a fenti kompozíció előállítására szolgálóeljárás és annak alkalmazása a hatóanyag gyors felszabadításitulajdonságaival rendelkező kompozíció előállítására. Ó
HU0100303A 1997-11-28 1998-11-19 Porous hydroxyapatite particles as carriers for drug substances HUP0100303A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704400A SE9704400D0 (sv) 1997-11-28 1997-11-28 Porous inorganic particles as carriers for drug substances
PCT/SE1998/002089 WO1999027912A1 (en) 1997-11-28 1998-11-19 Porous hydroxyapatite particles as carriers for drug substances

Publications (2)

Publication Number Publication Date
HUP0100303A2 true HUP0100303A2 (hu) 2001-08-28
HUP0100303A3 HUP0100303A3 (en) 2004-03-29

Family

ID=20409177

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100303A HUP0100303A3 (en) 1997-11-28 1998-11-19 Porous hydroxyapatite particles as carriers for drug substances

Country Status (26)

Country Link
US (1) US6558703B1 (hu)
EP (1) EP1032370B1 (hu)
JP (1) JP2001524513A (hu)
KR (1) KR20010032557A (hu)
CN (1) CN1280492A (hu)
AR (1) AR016683A1 (hu)
AT (1) ATE256453T1 (hu)
AU (1) AU752044B2 (hu)
BR (1) BR9814751A (hu)
CA (1) CA2311780A1 (hu)
DE (1) DE69820674T2 (hu)
DK (1) DK1032370T3 (hu)
ES (1) ES2210840T3 (hu)
HU (1) HUP0100303A3 (hu)
ID (1) ID24700A (hu)
IL (1) IL136146A0 (hu)
NO (1) NO20002719L (hu)
NZ (1) NZ504353A (hu)
PL (1) PL340927A1 (hu)
PT (1) PT1032370E (hu)
RU (1) RU2219907C2 (hu)
SE (1) SE9704400D0 (hu)
SK (1) SK6602000A3 (hu)
TW (1) TW524694B (hu)
WO (1) WO1999027912A1 (hu)
ZA (1) ZA9810463B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924334D0 (en) * 1999-10-15 1999-12-15 Secr Defence Pharmaceutical products and methods of fabrication therefor
AU2001246883B2 (en) 2000-04-11 2004-08-12 Sankyo Company, Limited Stabilized pharmaceutical compositions containing calcium channel blockers
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
KR101207553B1 (ko) 2005-06-02 2012-12-03 (주)씨앤팜 금속 이중층 수산화물을 포함하는 생체 주사제용 약물 담체
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
JP5027410B2 (ja) * 2005-12-13 2012-09-19 株式会社サンギ ユビキノン含有組成物
US20100040668A1 (en) * 2006-01-12 2010-02-18 Rutgers, The State University Of New Jersey Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
US8287914B2 (en) * 2006-01-12 2012-10-16 Rutgers, The State University Of New Jersey Biomimetic hydroxyapatite synthesis
GB0909460D0 (en) 2009-06-02 2009-07-15 Intrinsiq Materials Global Ltd Mesoporus material
EP2950923B1 (en) 2013-02-01 2022-03-09 W.R. Grace & CO. - CONN. Porous silica gel as a carrier for liquid technologies
JP6441940B2 (ja) 2013-09-20 2018-12-19 ティロッツ・ファルマ・アクチエンゲゼルシャフトＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 遅延放出製剤処方物
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
GB8713263D0 (en) 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
US5055307A (en) 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
US5947893A (en) * 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein

Also Published As

Publication number Publication date
JP2001524513A (ja) 2001-12-04
ES2210840T3 (es) 2004-07-01
SE9704400D0 (sv) 1997-11-28
ZA9810463B (en) 1999-05-21
NO20002719L (no) 2000-07-28
AU752044B2 (en) 2002-09-05
US6558703B1 (en) 2003-05-06
RU2219907C2 (ru) 2003-12-27
EP1032370B1 (en) 2003-12-17
DK1032370T3 (da) 2004-03-15
ATE256453T1 (de) 2004-01-15
EP1032370A1 (en) 2000-09-06
AR016683A1 (es) 2001-07-25
HUP0100303A3 (en) 2004-03-29
PT1032370E (pt) 2004-05-31
CA2311780A1 (en) 1999-06-10
AU1356399A (en) 1999-06-16
WO1999027912A1 (en) 1999-06-10
DE69820674T2 (de) 2004-09-30
BR9814751A (pt) 2000-10-03
PL340927A1 (en) 2001-03-12
CN1280492A (zh) 2001-01-17
IL136146A0 (en) 2001-05-20
DE69820674D1 (de) 2004-01-29
SK6602000A3 (en) 2001-01-18
NZ504353A (en) 2001-10-26
ID24700A (id) 2000-08-03
TW524694B (en) 2003-03-21
NO20002719D0 (no) 2000-05-26
KR20010032557A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
HUP0100303A2 (hu) Porózus hidroxiapatit részecskék mint gyógyszerhatóanyag hordozók
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
ES2054069T3 (es) Composicion cosmetica o farmaceutica que contiene microesferas de polimeros o de cuerpos grasos cargados de al menos un producto activo.
HUP0402280A2 (hu) Mikronizált filmképző por, az ezt tartalmazó készítmények, eljárások ezek előállítására, és ezek alkalmazása
EE9800383A (et) Meetod bioloogiliselt sobivate biodegradeeruvate mikroosakeste valmistamiseks, mikroosakesed ja nendest koosnev materjal, farmatseutiline kompositsioon ning mikroosakeste kasutamine
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
HRP20010463B1 (en) Controlled release galantamine composition
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
ATE163042T1 (de) Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
CL2004001191A1 (es) Compuestos derivados de esteroides 17 alpha-fluoroalquilados, con actividad antigestagena; composicion farmaceutica; combinacion farmaceutica; y uso del compuesto en la preparacion de un medicamento antiestrogenico, para el tratamiento de dismenorrea
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
DE69917609D1 (de) Arzneimittel und deren verwendung
FR2624863B1 (fr) Nouvelle forme cristalline de la ciclosporine, sa preparation et les compositions pharmaceutiques la contenant
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
HUP0103216A2 (hu) Gasztrointesztinális hatóanyagokat tartalmazó mukoadhezív készítmények
DE69716469D1 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
JP2001524513A5 (hu)
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
ES2183172T3 (es) Procedimiento para la preparacion de microparticulas.
AU7125991A (en) Novel antiulcer substance
DE3783923T3 (de) Einen Wirkstoff und ein in Wasser quellendes Polymer enthaltendes Arzneimittel.
HUP0202228A2 (hu) Kis dózist tartalmazó tabletták és eljárás előállításukra
FR2791980B1 (fr) Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
ATE347886T1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen